All News Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
7,27,000 ^KRW	-0.68%		-3.07%	-4.34%

06/06	Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	DJ
31/05	Samsung Biologics Aims to Lower Greenhouse Gas Emissions by 2030	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06/06	DJ
Samsung Biologics Aims to Lower Greenhouse Gas Emissions by 2030	31/05	MT
Samsung Biologics : Innovative solutions for bioprocessing challenges how MSAT drives efficient tech transfer	27/05	PU
US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz	23/05	MT
Samsung Biologics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Samsung Group Firms Set to Invest in US-based Latus Bio	06/05	MT
Samsung Biologics Reports First Quarter 2024 Financial Results	25/04	AQ
Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe	25/04	MT
Samsung Biologics Posts Higher Q1 Profit, Sales	25/04	MT
Samsung Biologics Boosts Contract Size with MSD Switzerland	08/04	MT
Samsung Life Science Fund Invests in BrickBio	20/03	AQ
Samsung Life Science Fund Invests in Biologics Developer	20/03	MT
CEO IR Newsletter : 2024 AGM Wrap Up	15/03	PU
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	15/03	PU
Samsung Group Initiates Open Hiring Drive for New Talent Acquisition	12/03	MT
South Korean Shares Close Higher After US Fed Chief Hints at Rate Cuts; Samsung Biologics Adds 1%	07/03	MT
Samsung Biologics Strikes $353 Million Deal with Belgium's UCB	07/03	MT
Samsung Biologics signs MOU with Seoul National University to foster bio experts	01/03	AQ
South Korean Shares Dip on Tech, Pharma Losses; Celltrion Sheds 5% on Lackluster Q4 Earnings	29/02	MT
Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

All News

Filters